Weight Loss GLP-1 Injection Peptide 99% Purity glp1 agonist Tirzepatide Comings
TDS 2099 Inquiries
2023788-19-2
Top Product
99%
shanghai
COMINGS
1g,50g,100g,1000g
2025-06-26
semaglutide,tirzepatide,Liraglutide,Retatrutide,5-amino-1MQ,SLU-PP-332
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.
Certificates-
TDS
Basic Info-
Product Name:
Tirzepatide
Other Name:LY3298176;
CAS No.:2023788-19-2
Molecular Formula:C225H348N48O68
Molecular Weight:4813
EC Number:200-001-8
Categories:
Characteristics-
Appearance:
White to off-white
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
semaglutide,tirzepatide,Liraglutide,Retatrutide,5-amino-1MQ,SLU-PP-332
-
Location:
No. 1, 19th Floor, Unit 2, Building 5, Southeast Residential Building (Hankou Yujiang Lanting), at the intersection of Hanshi Highway and Fufa South Road, Wuhu Street, Huangpi District, Wuhan City, Hu
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
15 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2023
-
-
Inquiry History2099 Inquiries
Country Product Purchase Quantity Date Posted
Philippines
Tirzepatide
2 MT Oct 27, 2026
Philippines
Tirzepatide
30 MG Oct 26, 2026
Slovakia
Tirzepatide
1 G Oct 26, 2026
France
Tirzepatide
1 KG Oct 25, 2026
United States
Tirzepatide
2.5 MG Oct 25, 2026
United Kingdom
Tirzepatide
5 MT Oct 25, 2026
United Kingdom
Tirzepatide
6 MT Oct 24, 2026
Peru
tirzepatide
10 MG Oct 21, 2026
Puerto Rico
tirzepatide
40 MG Oct 21, 2026
United States
Tirzepatide
10 MT Oct 21, 2026
South Africa
Tirzepatide
1 MT Oct 20, 2026
United States
Tirzepatide
5 KG Oct 20, 2026
United States
tirzepatide
30 MG Oct 20, 2026
United States
Tirzepatide
50 MG Oct 20, 2026
Spain
tirzepatide
20 MG Oct 19, 2026
United States
tirzepatide
30 MG Oct 19, 2026
Philippines
tirzepatide
40 MG Oct 19, 2026
United States
tirzepatide
50 MG Oct 19, 2026
United States
tirzepatide
50 MG Oct 19, 2026
United States
Tirzepatide
20 MG Oct 19, 2026 Post an enquiry for this product
More from this Seller
-
-
-
1-Butyl-3-methylimidazolium Bromide CAS85100-77-2
Top Product / 99%
-
-
-
-
Factory supply Calcium L-Threonate CAS70753-61-6 with good price
Top Product / 99%
-
-
-
-
Good price supply Kisspeptin-10 cas374675-21-5 with high purity
Pharmaceutical Grade / 99%
-
-
-
-
Haireloss treatment raw powder WAY316606 CAS915759-45-4 with high purity
Top Product / 99%
-
-
-
-
cas59587-09-6 N-Acetyl-L-cysteine ethyl ester NACET with good price
Top Product / 99%
-
-
-
-
Factory supply cas2521-07-5 9-Methyl-9H-beta-carboline with good price
Pharmaceutical Grade / 99%
-





